0001628280-23-023215.txt : 20230623 0001628280-23-023215.hdr.sgml : 20230623 20230623095419 ACCESSION NUMBER: 0001628280-23-023215 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20230623 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20230623 DATE AS OF CHANGE: 20230623 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aquestive Therapeutics, Inc. CENTRAL INDEX KEY: 0001398733 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208623253 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38599 FILM NUMBER: 231035179 BUSINESS ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-941-1900 MAIL ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: MonoSol Rx, Inc. DATE OF NAME CHANGE: 20070507 8-K 1 aqst-20230623.htm 8-K aqst-20230623
0001398733false00013987332023-06-212023-06-21

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): June 23, 2023
Aquestive Therapeutics, Inc.
(Exact name of Registrant as specified in its charter)
Delaware001-3859982-3827296
(State or Other Jurisdiction of Incorporation or Organization)(Commission File Number)(I.R.S. Employer Identification No.)

30 Technology Drive
Warren, NJ 07059
(908) 941-1900
(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)

Not Applicable
(Former name or former address, if changed since last report)

________________________________________________________________________________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which
registered
Common Stock, par value $0.001 per shareAQSTNasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.07 Submission of Matters to a Vote of Security Holders

(a)Aquestive Therapeutics, Inc. (the “Company”) held its 2023 Annual Meeting of Stockholders (the “Annual Meeting”) on June 21, 2023.

(b)The final voting results on each of the matters submitted to a vote of stockholders at the Annual Meeting are set forth below.

(1)The following director nominee was elected to serve as Class II member of the Board of Directors, to serve for a three-year term until the Company’s 2026 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified:

Nominee

Votes For
Votes Against
Votes
Abstaining

Broker Non-Votes
Gregory B. Brown, M.D.
24,757,783—1,830,86414,144,277
John S. Cochran24,886,102—1,702,54514,144,277

(2)The proposal to approve an amendment to the 2018 Equity Incentive Plan was approved.

Votes For
Votes Against
Votes
Abstaining
18,972,3087,272,348343,991

(3)The proposal to approve an amendment to the Amended and Restated Certificate of Incorporation was not approved.

Votes For
Votes Against
Votes
Abstaining
22,312,4013,252,6991,021,036

(4)The appointment of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2023 was ratified.

Votes For
Votes Against
Votes
Abstaining
40,091,281438,344203,299

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: June 23, 2023
Aquestive Therapeutics, Inc.
   
 By:/s/ A. Ernest Toth, Jr
  Name: A. Ernest Toth, Jr.
  Title: Chief Financial Officer
         (Principal Financial Officer)





 EX-101.SCH 2 aqst-20230623.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 aqst-20230623_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Trading Symbol Trading Symbol Entity File Number Entity File Number Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Soliciting Material Soliciting Material Entity Address, City or Town Entity Address, City or Town Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Local Phone Number Local Phone Number Entity Address, Postal Zip Code Entity Address, Postal Zip Code Written Communications Written Communications City Area Code City Area Code Cover [Abstract] Title of 12(b) Security Title of 12(b) Security Document Type Document Type Entity Ex Transition Period Entity Ex Transition Period Amendment Flag Amendment Flag Security Exchange Name Security Exchange Name Entity Registrant Name Entity Registrant Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Address, State or Province Entity Address, State or Province Document Period End Date Document Period End Date Pre-commencement Tender Offer Pre-commencement Tender Offer EX-101.PRE 4 aqst-20230623_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover
Jun. 21, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jun. 23, 2023
Entity Registrant Name Aquestive Therapeutics, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-38599
Entity Tax Identification Number 82-3827296
Entity Address, Address Line One 30 Technology Drive
Entity Address, City or Town Warren
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 07059
City Area Code 908
Local Phone Number 941-1900
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol AQST
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Central Index Key 0001398733
Amendment Flag false
XML 6 aqst-20230623_htm.xml IDEA: XBRL DOCUMENT 0001398733 2023-06-21 2023-06-21 0001398733 false 8-K 2023-06-23 Aquestive Therapeutics, Inc. DE 001-38599 82-3827296 30 Technology Drive Warren NJ 07059 908 941-1900 false false false false Common Stock, par value $0.001 per share AQST NASDAQ true false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( ,A.UU8'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " #(3M=6@]/Y.>\ K @ $0 &1O8U!R;W!S+V-O&ULS9+/ M3L,P#(=?!>7>NG^@AZC+98@32$A, G&+'&^+:-HH,6KW]K1AZX3@ 3C&_N7S M9\DM>HE#H.

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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 1 23 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://aquestive.com/role/Cover Cover Cover 1 false false All Reports Book All Reports aqst-20230623.htm aqst-20230623.xsd aqst-20230623_lab.xml aqst-20230623_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "aqst-20230623.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 23 }, "contextCount": 1, "dts": { "inline": { "local": [ "aqst-20230623.htm" ] }, "labelLink": { "local": [ "aqst-20230623_lab.xml" ] }, "presentationLink": { "local": [ "aqst-20230623_pre.xml" ] }, "schema": { "local": [ "aqst-20230623.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "aqst", "nsuri": "http://aquestive.com/20230623", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aqst-20230623.htm", "contextRef": "ief625a6d6d554d62b030f10eb9465e22_D20230621-20230621", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://aquestive.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "aqst-20230623.htm", "contextRef": "ief625a6d6d554d62b030f10eb9465e22_D20230621-20230621", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aquestive.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aquestive.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aquestive.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aquestive.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aquestive.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aquestive.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aquestive.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aquestive.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aquestive.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aquestive.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aquestive.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aquestive.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aquestive.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aquestive.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aquestive.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aquestive.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aquestive.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aquestive.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aquestive.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aquestive.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aquestive.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aquestive.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://aquestive.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 13 0001628280-23-023215-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001628280-23-023215-xbrl.zip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